F
10b5-1 Plan
$ Value
$21K
Shares
6,347
Price
$3
Filed
Nov 17
Insider
Name
Aslan Fred
Title
President and CEO
CIK
0001909362
Roles
Director
Officer
Transaction Details
Transaction Date
2025-11-15
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
350,374
Footnotes
Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of restricted stock unit awards. | The reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on July 23, 2024. | The weighted average sale price for the transaction reported was $3.376, and the range of prices were between $3.19 and $3.53. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Filing Info
Aslan Fred's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-15 | ARTV | A | $0 |
| 2026-02-15 | ARTV | F | $58K |
| 2025-12-15 | ARTV | ▼ | $19K |
| 2025-12-12 | ARTV | A | $0 |
| 2025-12-12 | ARTV | D | — |
| 2025-12-12 | ARTV | D | — |
| 2025-12-12 | ARTV | D | — |
| 2025-12-12 | ARTV | D | — |
| 2025-12-12 | ARTV | D | — |
| 2025-12-12 | ARTV | D | — |
Other Insiders at ARTV (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Bush Jennifer
COO, CLO, Secy, Compliance Off
|
— | — | 2026-02-15 |
|
Horan Christopher
Chief Tech Operations Officer
|
— | — | 2026-02-15 |
| Sorg Elaine K. | — | — | 2026-02-18 |
|
Aslan Fred
President and CEO
|
— | — | 2026-02-15 |
|
Raymon Heather
SVP, Research and Development
|
— | — | 2026-02-15 |
|
Banerjee Subhashis
Chief Medical Officer
|
— | — | 2026-02-15 |